IB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT06819293
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Clear Renal Cell Carcinoma
Adult
Interventions
BIOLOGICAL:
IB-T101 injection
Sponsor
Grit Biotechnology